Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2010
05/25/2010CA2441352C Liquid formulations for the prevention and treatment of mucosal diseases and disorders
05/25/2010CA2440763C Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles
05/25/2010CA2434961C L-histidine in ophthalmic solutions
05/25/2010CA2426263C Nateglinide-containing preparation
05/25/2010CA2421512C Cosmetic and pharmaceutical compositions and their use
05/25/2010CA2420523C Controlled and sustained release properties of polyelectrolyte multilayer capsules
05/25/2010CA2419825C Hard capsule made from a polymer or copolymer formed by polymerizing at least one polymerizable vinyl monomer in the presence of polyvinylalcohol or a derivative thereof
05/25/2010CA2404111C A polysaccharide-polypeptide conjugate
05/25/2010CA2404083C Use of polyphosphate as a tooth erosion inhibitor in acidic compositions
05/25/2010CA2400444C Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption
05/25/2010CA2394471C External preparation for treating pruritus
05/25/2010CA2368621C Methods and compositions for treating solid tumors
05/25/2010CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds
05/25/2010CA2342121C Powdered mannitol and the procedure for preparing it
05/25/2010CA2269335C Platelet substitutes and conjugation methods suitable for their preparation
05/25/2010CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions
05/20/2010WO2010057188A2 Fast-acting, dietary supplement containing compositions and methods of producing the compositions
05/20/2010WO2010057109A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010WO2010057107A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010WO2010056872A2 Antimicrobial compositions
05/20/2010WO2010056598A2 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010WO2010056065A2 Method for preparing microspheres and microspheres produced thereby
05/20/2010WO2010056040A2 Novel erythropoietin conjugates bonded with a biocompatible polymer
05/20/2010WO2010055950A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010055473A1 Methods of treating tumor cells using rhcc protein, fragment or variant
05/20/2010WO2010055416A1 Dispersion and debundling of carbon nanotubes using gemini surfactant compounds
05/20/2010WO2010055358A1 Suppression of cancer
05/20/2010WO2010055260A1 Novel composition based on gamma-hydroxybutyric acid
05/20/2010WO2010055252A2 Plant-based granules
05/20/2010WO2010055122A1 Octenidine composition
05/20/2010WO2010054699A1 Conjugates of albumin binding domain
05/20/2010WO2010054507A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010WO2010037395A3 Mhc multimers in cancer vaccines and immune monitoring
05/20/2010WO2010034019A4 Transdermal drug delivery using an osmolyte and vasoactive agent
05/20/2010WO2010032008A3 Dendritic cell modulatory molecule
05/20/2010WO2010004287A3 Process for preparing microparticles
05/20/2010WO2009133204A3 Vector for use in medicine
05/20/2010WO2009106073A3 Mhc multimers in borrelia diagnostics and disease
05/20/2010WO2009033588A3 Self-controlled insulin delivery system
05/20/2010US20100125130 Tumour necrosis factor binding ligands
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125049 Polymer factor viii moiety conjugates
05/20/2010CA2743837A1 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010CA2743600A1 Method for preparing microspheres and microspheres produced thereby
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743419A1 Antimicrobial compositions
05/20/2010CA2743006A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010CA2742990A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010CA2742988A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010CA2742921A1 Octenidine composition
05/20/2010CA2742846A1 Releasable fusogenic lipids for nucleic acids delivery systems
05/20/2010CA2741929A1 Suppression of cancer
05/19/2010EP2186835A1 Tenside-free cosmetic, dermatological and pharmaceutical medium.
05/19/2010EP2186830A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
05/19/2010EP2186789A1 Method of producing reduced coenzyme q10 and method of stabilizing the same
05/19/2010EP2186509A2 Propofol transparent anaesthetic solution with low venous irritation
05/19/2010EP2186507A2 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP2185586A1 Immune modulation via c-type lectin
05/19/2010EP2185204A2 Conjugate comprising a selective estrogen receptor modulator and a ribosome inactivating toxin
05/19/2010EP2185203A1 Oxidized avidin with high residency time in the treated tissues
05/19/2010EP2185187A1 Subcutaneous administration of alpha-galatosidase a
05/19/2010EP2185143A2 Antimicrobial parenteral formulation
05/19/2010EP1727865B1 Particle-stabilised emulsions
05/19/2010EP1689783B1 Mutated anti-cd22 antibodies and immunoconjugates
05/19/2010EP1653815B1 Methods for reducing astringency
05/19/2010EP1463487B1 Liposomal delivery of vitamin e based compounds
05/19/2010EP1448584B1 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
05/19/2010EP1214097B9 Nucleic acids encoding polyepitope polypeptides
05/19/2010CN201469700U Wind-dispelling rod adopting sulphur as main raw materials
05/19/2010CN1994425B Soft capsule of 'Sheng Mai' and preparation method thereof
05/19/2010CN1985916B Anaer vagina cleaning effervescent tablet and its production process
05/19/2010CN1973901B Composite microsphere preparation of lactic acid-hydroxyacetic acid copolymer and its preparation process
05/19/2010CN1957920B Anti cancer slow release agent carrying fluorouracil and synergist
05/19/2010CN1939343B Bone-peptide sodium chloride injection and its making method
05/19/2010CN1927175B Compound recipe anticancer slow release injection comprising tetrazole violet
05/19/2010CN1923173B Anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof
05/19/2010CN1923171B Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof
05/19/2010CN1919174B Anticancer slow release agent including nimustine and its synergist
05/19/2010CN1875936B Anticancer sustained release agent containing clorfarabine and cytotoxic drug
05/19/2010CN1857227B Supercritical fluid aided double circulation process for carrying medicine onto polymer microballoon
05/19/2010CN101709073A Nucleotide phospholipid molecule and lipidosome and preparation method and application thereof
05/19/2010CN101708339A Nano floxuridine/stratiform thermometal hydroxide hybrid and preparation method thereof
05/19/2010CN101708338A Prodrug containing sterides structures and high dispersion preparation thereof
05/19/2010CN101708337A Preparation method of human serum albumin nano granules coated with oxaliplatin
05/19/2010CN101708336A Novel medicinal premixing auxiliary material
05/19/2010CN101708335A PH-sensitive dentritic polymer drug carrier
05/19/2010CN101708251A Method for granulating medicament for treating osteoporosis
05/19/2010CN101708247A Compound antivirus immune intensifier of Chinese herbal medicine
05/19/2010CN101708239A Low-sugar Kouyanning tablet
05/19/2010CN101708197A Soft capsule preparation of oleum fructus brucease and novel process thereof
05/19/2010CN101708188A Modified humic acid degradation product, preparation method and composition patch thereof
05/19/2010CN101708181A Scutellarin injection preparation
05/19/2010CN101708177A Medicine composition containing docetaxel and preparation method thereof
05/19/2010CN101708176A Solid film, rapidly dissolvable in liquids
05/19/2010CN101708175A Sustained release microsphere medicinal preparation using PHBHHx as carrier and method for preparing same
05/19/2010CN101708174A Plant empty capsule, soft capsule composition and preparation methods thereof
05/19/2010CN101708173A Soft capsule and application thereof
05/19/2010CN101708172A Enteric hollow capsule
1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 1712